Health
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals – Fintech Zoom
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals –
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individualsResearchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
CoronaVac is an inactivated SARS-CoV-2 vaccine developed by Chinese pharmaceutical…
-
Noosa News21 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News22 hours agoBidding for a good cause
-
Noosa News21 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay
-
Noosa News21 hours agoMurray Watt slams Queensland LNP renewable energy policy